- Home
- CELC vs PBF Comparison
CELC vs PBF Comparison
Compare CELC & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | PBF |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 4.0B |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CELC | PBF |
|---|---|---|
| Price | $114.28 | $43.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 10 |
| Target Price | ★ $106.63 | $32.60 |
| AVG Volume (30 Days) | 527.9K | ★ 3.5M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | N/A | ★ 69.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $24,508,200,000.00 |
| Revenue This Year | N/A | $1.73 |
| Revenue Next Year | N/A | $0.67 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.58 | $13.62 |
| 52 Week High | $120.32 | $47.18 |
Technical Indicators
Market Signals| Indicator | CELC | PBF |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 62.92 |
| Support Level | $97.75 | $27.35 |
| Resistance Level | $114.54 | $47.18 |
| Average True Range (ATR) | 5.14 | 2.92 |
| MACD | 0.36 | 0.31 |
| Stochastic Oscillator | 63.53 | 71.27 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines, and storage facilities. The Logistics segment consists solely of PBFX's operations.